Human medicines European public assessment report (EPAR): Kivexa, abacavir,lamivudine, Date of authorisation: 16/12/2004, Revision: 38, Status: Authorised
Union list of critical medicines - version 2.1 (revision 1)
Methodology for the annual review of the Union list of critical medicines
PSUSA/00002771/202506
The EFIM Exchange Programme application is now officially closed.
No further applications can be accepted at this time.
We will now begin the review process of all received applications. Applicants will be contacted once the evaluation process is completed.
Thank you for your interest in the programme. The next deadline for the Exchange Programme will be December 2026!
Human medicines European public assessment report (EPAR): Aprovel, irbesartan, Date of authorisation: 26/08/1997, Revision: 51, Status: Authorised
Agenda of the HMPC meeting 19-21 January 2026
European Shortages Monitoring Platform (ESMP)
Human medicines European public assessment report (EPAR): Rystiggo, rozanolixizumab, Date of authorisation: 05/01/2024, Revision: 9, Status: Authorised
Human medicines European public assessment report (EPAR): Namuscla, mexiletine hcl, Date of authorisation: 18/12/2018, Revision: 8, Status: Authorised